Hiroichi Ishikawa

2.9k total citations
132 papers, 2.0k citations indexed

About

Hiroichi Ishikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Hiroichi Ishikawa has authored 132 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 33 papers in Epidemiology. Recurrent topics in Hiroichi Ishikawa's work include Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (33 papers) and Lung Cancer Research Studies (30 papers). Hiroichi Ishikawa is often cited by papers focused on Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (33 papers) and Lung Cancer Research Studies (30 papers). Hiroichi Ishikawa collaborates with scholars based in Japan, United States and Canada. Hiroichi Ishikawa's co-authors include Hiroaki Satoh, Koichi Kurishima, Morio Ohtsuka, Katsunori Kagohashi, Nobuyuki Hizawa, Kiyohisa Sekizawa, Tomohiro Tamura, Kensuke Nakazawa, Hiromichi Suzuki and Takahide Kodama and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroichi Ishikawa

129 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroichi Ishikawa Japan 23 1.1k 717 381 284 231 132 2.0k
Rex Yung United States 22 1.1k 1.0× 526 0.7× 355 0.9× 375 1.3× 254 1.1× 56 2.0k
Kazuma Kishi Japan 25 1.7k 1.5× 396 0.6× 392 1.0× 198 0.7× 244 1.1× 187 2.4k
Kuan‐Yu Chen Taiwan 20 998 0.9× 510 0.7× 289 0.8× 291 1.0× 187 0.8× 43 1.7k
Bryan M. Burt United States 33 1.1k 1.0× 869 1.2× 406 1.1× 390 1.4× 613 2.7× 109 3.0k
William P. Vaughan United States 30 610 0.5× 868 1.2× 408 1.1× 364 1.3× 224 1.0× 89 2.8k
Andrew W. Maksymiuk Canada 25 665 0.6× 1.3k 1.8× 508 1.3× 573 2.0× 160 0.7× 56 2.3k
Go Kimura Japan 25 1.0k 0.9× 550 0.8× 238 0.6× 573 2.0× 367 1.6× 167 2.4k
John Kim Canada 27 815 0.7× 773 1.1× 221 0.6× 290 1.0× 801 3.5× 66 2.6k
É. Lemarié France 22 1.1k 1.0× 929 1.3× 306 0.8× 334 1.2× 97 0.4× 105 1.9k
David W. Gjertson United States 31 753 0.7× 239 0.3× 365 1.0× 274 1.0× 478 2.1× 63 2.6k

Countries citing papers authored by Hiroichi Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Hiroichi Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroichi Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroichi Ishikawa more than expected).

Fields of papers citing papers by Hiroichi Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroichi Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroichi Ishikawa. The network helps show where Hiroichi Ishikawa may publish in the future.

Co-authorship network of co-authors of Hiroichi Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroichi Ishikawa. A scholar is included among the top collaborators of Hiroichi Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroichi Ishikawa. Hiroichi Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanabe, Naoya, Hiroaki Iijima, Ryo Sakamoto, et al.. (2024). Centrilobular emphysema and airway dysanapsis: factors associated with low respiratory function in younger smokers. ERJ Open Research. 10(2). 695–2023. 3 indexed citations
2.
Tanabe, Naoya, Hiroaki Iijima, Yusuke Shiraishi, et al.. (2022). Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features. Respiratory Medicine. 204. 107011–107011. 3 indexed citations
3.
Ichimura, Hideo, Shinji Kikuchi, Koichi Kurishima, et al.. (2016). Endobronchial dental prosthesis retrieval by a snare technique using a flexible bronchoscope and fluoroscopy: Two case reports and technical tips. Respiratory Medicine Case Reports. 19. 187–189. 3 indexed citations
4.
Satoh, Hiroaki, Katsunori Kagohashi, Gen Ohara, et al.. (2012). [A case of thymoma and Mycobacterium intracellulare infection].. PubMed. 87(11). 701–5. 2 indexed citations
5.
Kurishima, Koichi, Hiroaki Satoh, Katsunori Kagohashi, et al.. (2009). Patients With Lung Cancer With Metachronous or Synchronous Gastric Cancer. Clinical Lung Cancer. 10(6). 422–425. 5 indexed citations
6.
Satoh, Hiroaki, Hiroichi Ishikawa, Gen Ohara, et al.. (2008). Long-term survivors after chemotherapy in advanced non-small cell lung cancer.. PubMed. 27(6C). 4457–60. 23 indexed citations
7.
Satoh, Hiroaki, et al.. (2007). Psychotropic drugs for terminally ill patients with respiratory disease.. PubMed. 55(1). 5–10. 2 indexed citations
8.
Suzuki, Hisashi, Shigemi Ishikawa, Hiroaki Satoh, et al.. (2007). Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. 32(4). 648–652. 21 indexed citations
9.
Kodama, Takahide, Hiroaki Satoh, Hiroichi Ishikawa, & Morio Ohtsuka. (2007). Serum Levels of CA19‐9 in patients with nonmalignant respiratory diseases. Journal of Clinical Laboratory Analysis. 21(2). 103–106. 58 indexed citations
10.
Kagohashi, Katsunori, Hiroaki Satoh, Koichi Kurishima, Hiroichi Ishikawa, & Morio Ohtsuka. (2006). Body mass index and lung cancer risk in never smokers. Radiology and Oncology. 40(4). 4 indexed citations
11.
Kurishima, Koichi, Hiroaki Satoh, Shinsuke Homma, et al.. (2005). Multiple primary malignancies in patients with lung cancer. Radiology and Oncology. 39(1). 5 indexed citations
12.
Satoh, Hiroaki, et al.. (2005). Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis. Journal of Clinical Laboratory Analysis. 19(4). 146–149. 22 indexed citations
13.
Kagohashi, Katsunori, Hiroaki Satoh, Hiroichi Ishikawa, Morio Ohtsuka, & Kiyohisa Sekizawa. (2003). BONE METASTASIS AS THE FIRST MANIFESTATION OF LUNG CANCER. International Journal of Clinical Practice. 57(3). 184–186. 16 indexed citations
14.
Satoh, Hiroaki, Hiroichi Ishikawa, Morio Ohtsuka, & Kiyohisa Sekizawa. (2002). Spontaneous regression of pulmonary bullae. Australasian Radiology. 46(1). 106–107. 2 indexed citations
15.
Kurishima, Koichi, et al.. (2001). Lung Cancer in the Octogenarian. Gerontology. 47(3). 158–160. 7 indexed citations
16.
Ishikawa, Hiroichi, Hiroaki Satoh, Y. Yamashita, et al.. (1998). Curved chest tube for drainage of malignant pleural effusion. Respiratory Medicine. 92(4). 633–637. 4 indexed citations
17.
Ishikawa, Hiroichi, Hiroaki Satoh, S Hasegawa, et al.. (1997). Urokinase-type plasminogen activator in carcinomatous pleural fluid. European Respiratory Journal. 10(7). 1566–1571. 9 indexed citations
18.
Ishikawa, Hiroichi, Hiroaki Satoh, Takashi Naito, et al.. (1996). Lung Cancer in Ibaraki Prefecture: Summary of Clinical Assessment in 1100 Cases, with Special Reference to The Reasons for Detection of the Cancer.. Haigan. 36(7). 885–891. 1 indexed citations
19.
Yoshizawa, Yasuyuki, T. Sato, Hiroichi Ishikawa, et al.. (1995). A Compartmentalized Bias for T-Cell Receptor Vβ Usage in Summer-Type Hypersensitivity Pneumonitis. International Archives of Allergy and Immunology. 107(4). 581–586. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rex Yung Breakdown of academic impact, for papers by Kazuma Kishi Breakdown of academic impact, for papers by Kuan‐Yu Chen Breakdown of academic impact, for papers by Bryan M. Burt Breakdown of academic impact, for papers by William P. Vaughan Breakdown of academic impact, for papers by Andrew W. Maksymiuk Breakdown of academic impact, for papers by Go Kimura Breakdown of academic impact, for papers by John Kim Breakdown of academic impact, for papers by É. Lemarié Breakdown of academic impact, for papers by David W. Gjertson
Rankless by CCL
2026